Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 27/11/2020
SIETES contiene 93167 citas

 
 
 1 a 20 de 396 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Musso G, Gambino R, Cassader M, Paschetta E. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2019;365:9 de abril. [Ref.ID 103085]
2. Cita con resumen
Grosser T, Ricciotti E, Fitzgerald GA. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci 2017;38:733-48. [Ref.ID 101990]
3.Enlace a cita original
Kyriacou DN, Lewis RJ. Confounding by indication in clinical research. JAMA 2016;316:1818-9. [Ref.ID 100935]
4. Cita con resumen
Lip GYH, Skjoth F, Rasmussen LH, Larsen TB. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol 2015;65:1385-94. [Ref.ID 98892]
5. Cita con resumen
Roberts E, Nunes VD, Buckner S, Latchem S, Constanti M, Miller P, Doherty M, Zhang W, Birrell F, Porcheret M, Dziedzic K, Bernstein I, Wise E, Conaghan PG. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis 2015:4 de marzo. [Ref.ID 98867]
6. Cita con resumen
Laporte JR, Bosch M. Re: Meta-analysis of side effects of statins shows need for trial transparency. BMJ 2014:2 de mayo. [Ref.ID 98148]
7.Enlace a cita original
Manno D, Ker K, Roberts I. How effective is tranexamic acid for acute gastrointestinal bleeding?. BMJ 2014;348:g1421. [Ref.ID 97353]
8.Tiene citas relacionadas Cita con resumen
The HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014;371:203-12. [Ref.ID 97194]
9. Cita con resumen
Wong WB, Lin VW, Boudreau D, Devine EB. Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol Drug Saf 2013;22:345-58. [Ref.ID 95209]
10.
Schriger DL, Savage DF, Altman DG. Presentation of continuous outcomes in randomised trials: an observational study. BMJ 2013;346:15. [Ref.ID 94760]
11.Tiene citas relacionadas Cita con resumen
Devanand DP, Schultz SK, Sultzer DL. Discontinuation of risperidone in Alzheimer's disease. Author/editor response. N Engl J Med 2013;368:187-8. [Ref.ID 94751]
12.Tiene citas relacionadas Cita con resumen
Ling SM, Bonner AF, McMullen TL. Discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2013;368:187. [Ref.ID 94750]
13.Tiene citas relacionadas Cita con resumen
Power GA. Discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2013;368:186-7. [Ref.ID 94749]
14.Tiene citas relacionadas Cita con resumen
Gnjidic D, Hilmer SN. Discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2013;368:186. [Ref.ID 94748]
15. Cita con resumen
Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, Nourjah P, Sauer B, Schumock GT, Sedrakyan A, Sürmer T, West SL, Schneeweiss S. The incidence user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf 2013;22:1-6. [Ref.ID 94655]
16.Tiene citas relacionadas Cita con resumen
de Gage SB, Bégaud B, Pariente A. Benzodiazepines and dementia. Authors' reply. BMJ 2012;345:28-9. [Ref.ID 94180]
17.Tiene citas relacionadas Cita con resumen
Bocti C, Roy-Desruisseaux J. Benzodiazepines and dementia. ... but reflects treatment of early dementia. BMJ 2012;345:28. [Ref.ID 94179]
18.Tiene citas relacionadas Cita con resumen
Coyle-Gilchrist ITS, Peck LF, Rowe JB. Benzodiazepines and dementia. Link is not causal.... BMJ 2012;345:28. [Ref.ID 94178]
19.Tiene citas relacionadas Cita con resumen
Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH. Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2012;367:1497-507. [Ref.ID 93889]
20. Cita con resumen
Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012;344:20. [Ref.ID 92611]
Seleccionar todas
 
 1 a 20 de 396 siguiente >>